Dear Doctor - Participate in the Survey on Childhood asthma " A new study has found that childhood asthma is on the rise in the United States. The study, which was conducted by the Centers for Disease Control and Prevention (CDC), found that the number of children with asthma increased by 4 percent between 2001 and 2009.The CDC attributes the increase in childhood asthma to a number of factors, including exposure to environmental triggers such as pollution and allergens, and a decrease in the age at which children are diagnosed with the condition. The study also found that African American children are more likely to have asthma than their Caucasian counterparts.The findings of this study underscore the need for better proactive measures to prevent and control childhood asthma. This includes creating awareness about environmental triggers and taking steps to reduce exposure to them. It is also important to ensure that children who do have asthma receive prompt and appropriate treatment so that they can manage their condition effectively. Participate in Surveys "
1.
New guidelines for radiation therapy for HPV-associated head and neck cancer
2.
Review looks at potential treatment targets in the tumor microenvironment.
3.
Even when they are not paying attention, children are still learning.
4.
The Benefits of Exercise for Substance Use Disorders.
5.
The top three drugs for multiple myeloma treatment upfront are four.
1.
The New Era of Oncology: Key Updates and Clinical Insights
2.
Everything You Need to Know About RDW-CV: A Comprehensive Guide
3.
Decoding Granular Cell Tumor: What You Need to Know
4.
Subchorionic Hematoma: Causes, Symptoms, and Treatment
5.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
2.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
3.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
4.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
5.
Navigating the Complexities of Ph Negative ALL - Part XI
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation